Cargando…
Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice
INTRODUCTION: Chikungunya virus (CHIKV) is a re-emerging pathogen responsible for causing outbreaks of febrile disease accompanied with debilitating joint pain. Symptoms typically persist for two weeks, but more severe and chronic chikungunya illnesses have been reported, especially in the elderly....
Autores principales: | Arévalo, Maria T., Huang, Ying, Jones, Cheryl A., Ross, Ted M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485612/ https://www.ncbi.nlm.nih.gov/pubmed/31026260 http://dx.doi.org/10.1371/journal.pntd.0007316 |
Ejemplares similares
-
Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
por: Metz, Stefan W., et al.
Publicado: (2013) -
Characterization of Chikungunya Virus-Like Particles
por: Noranate, Nitchakarn, et al.
Publicado: (2014) -
Evaluation of DNA-Launched Virus-Like Particle Vaccines in an Immune Competent Mouse Model of Chikungunya Virus Infection
por: Rayner, Jonathan O., et al.
Publicado: (2021) -
Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
por: Garg, Himanshu, et al.
Publicado: (2020) -
Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles
por: Jang, Hyesun, et al.
Publicado: (2021)